3696

InSilico Medicine Cayman TopCo Stock Price

SEHK:3696 Community·HK$30.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

3696 Share Price Performance

HK$55.15
25.17 (83.96%)
HK$55.15
25.17 (83.96%)
Price HK$55.15

3696 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with low risk.

3 Risks
0 Rewards

InSilico Medicine Cayman TopCo Key Details

US$53.6m

Revenue

US$8.8m

Cost of Revenue

US$44.8m

Gross Profit

US$89.1m

Other Expenses

-US$44.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.08
83.56%
-82.72%
0%
View Full Analysis

About 3696

Founded
2014
Employees
n/a
CEO
Alexander Zhavoronkov
WebsiteView website
insilico.com

InSilico Medicine Cayman TopCo operates as an artificial intelligence (AI)-based biotech company that helps to develop and manufacture novel drugs in Hong Kong, the United States, the United Kingdom, Mainland China, and internationally. The company develops solutions to discover and develop drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. It also offers Pharma.AI platform, a commercially end-to-end generative Al software and automation platform which is designed to enhance the quality and productivity of pharmaceutical research. The company was founded in 2014 and is based in New Territories, Hong Kong.

Recent 3696 News & Updates

Recent updates

No updates